IFNA1 and cancer: The first aim of our study, therefore, was to compare (using the dual vaccination protocol) specific cytokine combinations (TNF-α +/- IFN-α) to generate activated and functional DCs from circulating CD14+ monocyte precursors in patients with advanced cancer.